StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$3.17+0.51 (+19.17%)

Close on Nov 18, 2026Market cap $117.87MP/E –Yield –

Armata Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Armata Pharmaceuticals's pe ratio was 1.5× on Jul 29, 2016, against 3.8× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2016Jul 29, 20161.5×−43.1
2015Dec 31, 201544.6×+41.3
2014Dec 31, 20143.2×–

More Armata Pharmaceuticals figures

See a number that looks wrong?